Back
Cellebrite DI 10K Form
Sell
27
CLBT
Cellebrite DI
Last Price:
$18.19
Seasonality Move:
7.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLBT News And Ratings
See the #1 stock for the next 7 days that we like better than CLBT
CLBT Financial Statistics
Sales & Book Value
| Annual Sales: | $401.2M |
|---|---|
| Cash Flow: | $61.7M |
| Price / Cash Flow: | 31.34 |
| Annual Sales: | $1.43 |
| Price / Book: | 12.96 |
Profitability
| EPS (TTM): | -1.39000 |
|---|---|
| Net Income (TTM): | $-283M |
| Gross Margin: | $338.6M |
| Return on Equity: | -235.18% |
| Return on Assets: | -48.16% |
Cellebrite DI Earnings Forecast
Key Cellebrite DI Financial Ratios
-
The Gross Profit Margin over the past 6 years for CLBT is 84.40%.
-
The Selling, General & Administrative Expenses for CLBT have been equal to 45.68% of Gross Profit Margin.
-
The Research & Development expenses have been 24.53% of Revenue.
-
The Net Earning history of CLBT is -70.54% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Cellebrite DI Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | CLBT |
| Website: | cellebrite.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.92 |
| Quick Ratio: | 1.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 36.83 |
CLBT Technical Analysis vs Fundamental Analysis
Sell
27
Cellebrite DI (CLBT)
is a Sell
Is Cellebrite DI a Buy or a Sell?
-
Cellebrite DI stock is rated a SellThe current Cellebrite DI [CLBT] share price is $18.19. The Score for CLBT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.